Advanced search
Publication Cover
Acta Oncologica Volume 34, 1995 - Issue 6
Journal homepage
410
Views
70
CrossRef citations to date
0
Altmetric
Original Article

The Prognostic Significance of ‘Stage, Tumor Size, Cellular Atypia and DNA Ploidy in Uterine Leiomyosarcoma

Randi R. Nordal Departments of Gynecologic Oncology, Pathology and Tissue Culture, The Norwegian Radium Hospital, Oslo, Norway
,
Gunnar B. Kristensen Departments of Gynecologic Oncology, Pathology and Tissue Culture, The Norwegian Radium Hospital, Oslo, Norway
,
Janne Kern Departments of Gynecologic Oncology, Pathology and Tissue Culture, The Norwegian Radium Hospital, Oslo, Norway
,
Anna E. Stenwig Departments of Gynecologic Oncology, Pathology and Tissue Culture, The Norwegian Radium Hospital, Oslo, Norway
,
Erik O. Pettersen Departments of Gynecologic Oncology, Pathology and Tissue Culture, The Norwegian Radium Hospital, Oslo, Norway
&
Claes G. Tropé Departments of Gynecologic Oncology, Pathology and Tissue Culture, The Norwegian Radium Hospital, Oslo, Norway
Pages 797-802 | Accepted 23 Jun 1995, Published online: 08 Jul 2009

Citations (70)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Joyce N Barlin & Robert L Giuntoli. (2009) Management of uterine leiomyosarcoma: an update. Expert Review of Obstetrics & Gynecology 4:5, pages 509-520.
Read now
Farid Moinfar, Masood Azodi & Fattaneh A. Tavassoli. (2007) Uterine sarcomas. Pathology 39:1, pages 55-71.
Read now
Klaus Mayerhofer, Plamen Lozanov, Klaus Bodner, Barbara Bodner-Adler, Oliver Kimberger & Klaus Czerwenka. (2004) Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS). Acta Obstetricia et Gynecologica Scandinavica 83:11, pages 1085-1088.
Read now
Chin-Hsiung Hsieh, Hao Lin, Chao-Cheng Huang, Eng-Yen Huang, Shiuh-Young Chang & Chan-Chao ChangChien. (2003) Leiomyosarcoma of the uterus: a clinicopathologic study of 21 cases. Acta Obstetricia et Gynecologica Scandinavica 82:1, pages 74-81.
Read now

Articles from other publishers (66)

Emily Hinchcliff, Barrett Lawson, Ravin Ratan & Pamela Soliman. 2023. Diagnosis and Treatment of Rare Gynecologic Cancers. Diagnosis and Treatment of Rare Gynecologic Cancers 145 160 .
Jomjit Chantharasamee, Karlton Wong, Pasathorn Potivongsajarn, Amir Qorbani, Neda Motamed, Sandra Brackert, Joshua Cohen, Bartosz Chmielowski, Anusha Kalbasi, Jianyu Rao, Scott Nelson & Arun Singh. (2022) Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma. Cancer Medicine 11:15, pages 2906-2912.
Crossref
David B. Chapel, Aarti Sharma, Ricardo R. Lastra, Livia Maccio, Emma Bragantini, Gian Franco Zannoni, Suzanne George, Bradley J. Quade, Carlos Parra-Herran & Marisa R. Nucci. (2022) A novel morphology-based risk stratification model for stage I uterine leiomyosarcoma: an analysis of 203 cases. Modern Pathology 35:6, pages 794-807.
Crossref
Ka-Yu Tse, Richard Wing-Cheuk Wong, Angel Chao, Shir-Hwa Ueng, Lan-Yan Yang, Margaret Cummings, Deborah Smith, Chiung-Ru Lai, Hei-Yu Lau, Ming-Shyen Yen, Annie Nga-Yin Cheung, Charlotte Ka-Lun Leung, Kit-Sheung Chan, Alice Ngot-Htain Chan, Wai-Hon Li, Carmen Ka-Man Choi, Wai-Mei Pong, Hoi-Fong Hui, Judy Ying-Wah Yuk, Hung Yao, Nancy Wah-Fun Yuen, Andreas Obermair, Chyong-Huey Lai, Philip Pun-Ching Ip & Hextan Yuen-Sheung Ngan. (2021) Development of a Multi-Institutional Prediction Model for Three-Year Survival Status in Patients with Uterine Leiomyosarcoma (AGOG11-022/QCGC1302 Study). Cancers 13:10, pages 2378.
Crossref
Kelly A. Devereaux & J. Kenneth Schoolmeester. (2019) Smooth Muscle Tumors of the Female Genital Tract. Surgical Pathology Clinics 12:2, pages 397-455.
Crossref
Esther Oliva, Charles J. Zaloudek & Robert A. Soslow. 2019. Blaustein's Pathology of the Female Genital Tract. Blaustein's Pathology of the Female Genital Tract 535 647 .
Sabrina Croce, Agnès Ducoulombier, Agnès Ribeiro, Tom Lesluyes, Jean-Christophe Noel, Frédéric Amant, Louis Guillou, Eberhard Stoeckle, Mojgan Devouassoux-Shisheboran, Nicolas Penel, Anne Floquet, Laurent Arnould, Frédéric Guyon, Florence Mishellany, Camille Chakiba, Tine Cuppens, Michal Zikan, Agnès Leroux, Eric Frouin, Isabelle Farre, Catherine Genestie, Isabelle Valo, Gaëtan MacGrogan & Frédéric Chibon. (2018) Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors. Modern Pathology 31:5, pages 816-828.
Crossref
Esther Oliva, Charles J. Zaloudek & Robert A. Soslow. 2018. Blaustein's Pathology of the Female Genital Tract. Blaustein's Pathology of the Female Genital Tract 1 115 .
Ketty Tavella, Alessandro Villanucci, Laura Vannini, Daniele Lavacchi, Silvia Montelatici, Gianni Amunni & Teresita Mazzei. (2017) Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin. Anti-Cancer Drugs 28:4, pages 465-468.
Crossref
Brandon-Luke L. Seagle, Janelle Sobecki-Rausch, Anna E. Strohl, Arunima Shilpi, Anne Grace & Shohreh Shahabi. (2017) Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study. Gynecologic Oncology 145:1, pages 61-70.
Crossref
Glauco Baiocchi, Fernando Luís Visoni Poliseli, Louise De Brot, Henrique Mantoan, Beatriz Nunes Schiavon, Carlos Chaves Faloppa, Jose Vassallo, Fernando Augusto Soares & Isabela Werneck Cunha. (2016) TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma . Journal of Clinical Pathology 69:10, pages 884-889.
Crossref
Olivia W. Foley, J. Alejandro Rauh-Hain, Joel Clemmer, Rachel M. Clark, Tracilyn Hall, Elisabeth J. Diver, John O. Schorge & Marcela G. del Carmen. (2015) Trends in the Treatment of Uterine Leiomyosarcoma in the Medicare Population. International Journal of Gynecological Cancer 25:3, pages 453-458.
Crossref
Patricia M. Baker & Esther Oliva. 2018. Uterine Cancer. Uterine Cancer 107 146 .
Marcela G. del Carmen. 2014. Uncommon Gynecologic Cancers. Uncommon Gynecologic Cancers 167 177 .
Rosanna Mancari, Mauro Signorelli, Angiolo Gadducci, Silvestro Carinelli, Elena De Ponti, Silvia Sesana, Silvia Corso, Valentina Chiappa, Nicoletta Colombo & Andrea Alberto Lissoni. (2014) Adjuvant chemotherapy in stage I–II uterine leiomyosarcoma: A multicentric retrospective study of 140 patients. Gynecologic Oncology 133:3, pages 531-536.
Crossref
Philip Wong, Kathy Han, Jenna Sykes, Charles Catton, Stephane Laframboise, Anthony Fyles, Lee Manchul, Wilfred Levin & Michael Milosevic. (2013) Postoperative radiotherapy improves local control and survival in patients with uterine leiomyosarcoma. Radiation Oncology 8:1.
Crossref
Kristelle Lusby, Kari Brewer Savannah, Elizabeth G. Demicco, Yiqun Zhang, Markus PH. Ghadimi, Eric D. Young, Chiara Colombo, Ryan Lam, Tugce E. Dogan, Jason L. Hornick, Alexander J. Lazar, Kelly K. Hunt, Matthew L. Anderson, Chad J. Creighton, Dina Lev & Raphael E. Pollock. (2013) Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution’s Experience. Annals of Surgical Oncology 20:7, pages 2364-2372.
Crossref
D. Lim, W.L. Wang, C.H. Lee, T. Dodge, B. Gilks & E. Oliva. (2013) Old versus new FIGO staging systems in predicting overall survival in patients with uterine leiomyosarcoma: A study of 86 cases. Gynecologic Oncology 128:2, pages 322-326.
Crossref
Pei-Shan Tan, Elisa Koh, Cindy Pang, Whee-Sze Ong, Lynette Ngo, Lay-Tin Soh, Richard Quek, Wen-Yee Chay, Tew-Hong Ho, Sun-Kuie Tay, Sung-Hock Chew, Soo-Kim Lim-Tan, Hs Khoo-TanSheow Lei LimInny BusmanisLiang Kee Goh, Yin-Nin ChiaWhay-Kuang Chia & Timothy Lim. (2012) Uterine Leiomyosarcoma in Asian Patients: Validation of the Revised Federation of Gynecology and Obstetrics Staging System and Identification of Prognostic Classifiers. The Oncologist 17:10, pages 1286-1293.
Crossref
Martee L. Hensley. (2012) Uterine Sarcomas: Histology and Its Implications on Therapy. American Society of Clinical Oncology Educational Book:32, pages 356-361.
Crossref
Ashot Avdalyan, Igor Bobrov, Vladimir Klimachev & Alexander Lazarev. (2012) Prognostic Value of Microvessel Density in Tumor and Peritumoral Area as Evaluated by CD31 Protein Expression and Argyrophilic Nucleolar Organizer Region Count in Endothelial Cells in Uterine Leiomyosarcoma. Sarcoma 2012, pages 1-11.
Crossref
Roberta Sanfilippo, Federica Grosso, Robin L. Jones, Susana Banerjee, Silvana Pilotti, Maurizio D'Incalci, Angelo Paolo Dei Tos, Francesco Raspagliesi, Ian Judson & Paolo Giovanni Casali. (2011) Trabectedin in advanced uterine leiomyosarcomas: A retrospective case series analysis from two reference centers. Gynecologic Oncology 123:3, pages 553-556.
Crossref
Angiolo Gadducci. (2011) Prognostic factors in uterine sarcoma. Best Practice & Research Clinical Obstetrics & Gynaecology 25:6, pages 783-795.
Crossref
Ka Yu Tse, Robin Crawford & Hextan Y.S. Ngan. (2011) Staging of uterine sarcomas. Best Practice & Research Clinical Obstetrics & Gynaecology 25:6, pages 733-749.
Crossref
Emanuela D'Angelo, Inigo Espinosa, Rola Ali, C. Blake Gilks, Matt van de Rijn, Cheng-Han Lee & Jaime Prat. (2011) Uterine leiomyosarcomas: Tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis. Gynecologic Oncology 121:2, pages 328-333.
Crossref
Charles J. Zaloudek, Michael R. Hendrickson & Robert A. Soslow. 2011. Blaustein’s Pathology of the Female Genital Tract. Blaustein’s Pathology of the Female Genital Tract 453 527 .
Gunjal Garg, Jay P. Shah, J. Rebecca Liu, Christopher S. Bryant, Sanjeev Kumar, Adnan Munkarah & Robert T. Morris. (2010) Validation of Tumor Size as Staging Variable in the Revised International Federation of Gynecology and Obstetrics Stage I Leiomyosarcoma. International Journal of Gynecological Cancer 20:7, pages 1201-1206.
Crossref
H.S. Kim, K.H. Han, H.H. Chung, J.W. Kim, N.H. Park, Y.S. Song & S.B. Kang. (2010) Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: A case-matched comparison. European Journal of Surgical Oncology (EJSO) 36:7, pages 691-698.
Crossref
Emanuela D'Angelo & Jaime Prat. (2010) Uterine sarcomas: A review. Gynecologic Oncology 116:1, pages 131-139.
Crossref
Chandrajit P. Raut, Marisa R. Nucci, Qian Wang, Judith Manola, Monica M. Bertagnolli, George D. Demetri, Jeffrey A. Morgan, Michael G. Muto, Christopher D.M. Fletcher & Suzanne George. (2009) Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma. European Journal of Cancer 45:16, pages 2818-2824.
Crossref
Ali Ayhan, Guldeniz Aksan, Murat Gultekin, Sertac Esin, Cigdem Himmetoglu, Polat Dursun, Alp Usubutun & Kunter Yuce. (2008) Prognosticators and the role of lymphadenectomy in uterine leiomyosarcomas. Archives of Gynecology and Obstetrics 280:1, pages 79-85.
Crossref
W. Kildal, V.M. Abeler, G.B. Kristensen, M. Jenstad, S.Ø. Thoresen & H.E. Danielsen. (2009) The prognostic value of DNA ploidy in a total population of uterine sarcomas. Annals of Oncology 20:6, pages 1037-1041.
Crossref
Oliver ZivanovicMario M. LeitaoAlexia IasonosLindsay M. JacksQin ZhouNadeem R. Abu-RustumRobert A. SoslowMargrit M. JuretzkaDennis S. ChiRichard R. BarakatMurray F. BrennanMartee L. Hensley. (2009) Stage-Specific Outcomes of Patients With Uterine Leiomyosarcoma: A Comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems. Journal of Clinical Oncology 27:12, pages 2066-2072.
Crossref
Manuela Pelmus, Frédérique Penault-Llorca, Louis Guillou, Françoise Collin, Gérard Bertrand, Martine Trassard, Agnès Leroux, Anne Floquet, Eberhard Stoeckle, Laurence Thomas & Gaëtan MacGrogan. (2009) Prognostic Factors in Early-Stage Leiomyosarcoma of the Uterus. International Journal of Gynecologic Cancer 19:3, pages 385-390.
Crossref
Martee L. Hensley, Nicole Ishill, Robert Soslow, Joseph Larkin, Nadeem Abu-Rustum, Paul Sabbatini, Jason Konner, William Tew, David Spriggs & Carol A. Aghajanian. (2009) Adjuvant gemcitabine plus docetaxel for completely resected stages I–IV high grade uterine leiomyosarcoma: Results of a prospective study. Gynecologic Oncology 112:3, pages 563-567.
Crossref
Vera M Abeler, Odd Røyne, Steinar Thoresen, Håvard E Danielsen, Jahn M Nesland & Gunnar B Kristensen. (2009) Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 54:3, pages 355-364.
Crossref
MICHAEL PETERSON, DAVID J. DABBS & NOEL WEIDNER. 2009. Modern Surgical Pathology. Modern Surgical Pathology 1295 1340 .
Patricia M. Baker & Esther Oliva. 2009. Uterine Cancer. Uterine Cancer 105 141 .
Robert A. Soslow. (2008) Uterine mesenchymal tumors: a review of selected topics. Diagnostic Histopathology 14:4, pages 175-188.
Crossref
Daniel S. Kapp, Jacob Y. Shin & John K. Chan. (2008) Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas. Cancer 112:4, pages 820-830.
Crossref
Caterina Exacoustos, Maria Elisabetta Romanini, Annalisa Amadio, Concetta Amoroso, Beata Szabolcs, Errico Zupi & Domenico Arduini. (2007) Can gray‐scale and color Doppler sonography differentiate between uterine leiomyosarcoma and leiomyoma?. Journal of Clinical Ultrasound 35:8, pages 449-457.
Crossref
Vanessa N Harry, Gordon V Narayansingh & David E Parkin. (2007) Uterine leiomyosarcomas: a review of the diagnostic and therapeutic pitfalls. The Obstetrician & Gynaecologist 9:2, pages 88-94.
Crossref
S.H. Kim, J.W. Kim, Y.T. Kim, J.H. Kim, B.S. Yoon & H.S. Ryu. (2006) Prognostic factors and expression of p53 and mdm-2 in uterine sarcomas. International Journal of Gynecology & Obstetrics 95:3, pages 272-277.
Crossref
Peter E. Schwartz & Michael G. Kelly. (2006) Malignant Transformation of Myomas: Myth or Reality?. Obstetrics and Gynecology Clinics of North America 33:1, pages 183-198.
Crossref
Igor Matushansky & Martee L Hensley. (2006) Leiomyosarcoma. American Journal of Cancer 5:2, pages 81-91.
Crossref
Sheetal Acharya, Martee L Hensley, Anthony C Montag & Gini F Fleming. (2005) Rare uterine cancers. The Lancet Oncology 6:12, pages 961-971.
Crossref
Avery A. Sandberg. (2005) Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma. Cancer Genetics and Cytogenetics 161:1, pages 1-19.
Crossref
Lorenzo Livi, Fabiola Paiar, Elisa Meldolesi, Gabriele Simontacchi, Gianni Amunni, Raffaella Barca, Alessandro Villanucci, Silvia Scoccianti, Gaia Piperno & Gianpaolo Biti. (2019) Treatment of Uterine Sarcoma at the University of Florence from 1980-2001. Tumori Journal 91:2, pages 139-143.
Crossref
Michael Hendrickson, Teri Longacre & Richard Kempson. 2004. Cancer of the Uterus. Cancer of the Uterus 149 194 .
L. Livi, E. Andreopoulou, N. Shah, F. Paiar, P. Blake, I. Judson & C. Harmer. (2004) Treatment of Uterine Sarcoma at the Royal Marsden Hospital from 1974 to 1998. Clinical Oncology 16:4, pages 261-268.
Crossref
Klaus Bodner, Barbara Bodner-AdlerOliver Kimberger, Klaus Czerwenka & Klaus Mayerhofer. (2016) Bcl-2 Receptor Expression in Patients With Uterine Smooth Muscle Tumors: An Immunohistochemical Analysis Comparing Leiomyoma, Uterine Smooth Muscle Tumor of Uncertain Malignant Potential, and Leiomyosarcoma. Journal of the Society for Gynecologic Investigation 11:3, pages 187-191.
Crossref
Klaus Bodner, Barbara Bodner-Adler, Oliver Kimberger, Klaus Czerwenka & Klaus Mayerhofer. (2004) Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors. Fertility and Sterility 81:4, pages 1062-1066.
Crossref
Klaus Bodner, Barbara Bodner-Adler, Oliver Kimberger, Klaus Czerwenka & Klaus Mayerhofer. (2004) Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcomaBcl-2 Expression und andere klinisch-pathologische Parameter belm Lelomyosarkom des Uterus. Wiener Klinische Wochenschrift 116:4, pages 135-139.
Crossref
Raimund Winter, Andrew G. Östör, Karin Kapp & Edgar Petru. 2004. Gynecologic Cancer. Gynecologic Cancer 301 316 .
L Livi, F Paiar, N Shah, P Blake, A Villanucci, G Amunni, R Barca, I Judson, N Lodge, E Meldolesi, G Simontacchi, G Piperno, A Galardi, S Scoccianti, G.P Biti & C Harmer. (2003) Uterine sarcoma: twenty-seven years of experience. International Journal of Radiation Oncology*Biology*Physics 57:5, pages 1366-1373.
Crossref
B. Bodner-Adler, K. Bodner, O. Kimberger, K. Czerwenka, S. Leodolter & K. Mayerhofer. (2016) MMP-1 and MMP-2 Expression in Uterine Leiomyosarcoma and Correlation With Different Clinicopathologic Parameters. Journal of the Society for Gynecologic Investigation 10:7, pages 443-446.
Crossref
Robert L GiuntoliIIII, Daniel S Metzinger, Connie S DiMarco, Stephen S Cha, Jeff A Sloan, Gary L Keeney & Bobbie S Gostout. (2003) Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy☆. Gynecologic Oncology 89:3, pages 460-469.
Crossref
Martee L. HensleyRobert MakiE. VenkatramanGennifer GellerMeghan LovegrenCarol AghajanianPaul SabbatiniWilliam TongRichard BarakatDavid R. Spriggs. (2002) Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma: Results of a Phase II Trial. Journal of Clinical Oncology 20:12, pages 2824-2831.
Crossref
Klaus Bodner, Barbara Bodner-Adler, Andreas Obermair, Gudrun Windbichler, Edgar Petru, Stephan Mayerhofer, Klaus Czerwenka, Sepp Leodolter, Christian Kainz & Klaus Mayerhofer. (2001) Prognostic Parameters in Endometrial Stromal Sarcoma: A Clinicopathologic Study in 31 Patients. Gynecologic Oncology 81:2, pages 160-165.
Crossref
Thomas Löning & Lutz RiethdorfT. Löning. 2001. Pathologie der weiblichen Genitalorgane III. Pathologie der weiblichen Genitalorgane III 653 704 .
Lester J. LayfieldKatharine LiuRichard DodgeSanford H. Barsky. (2000) Uterine Smooth Muscle Tumors. Archives of Pathology & Laboratory Medicine 124:2, pages 221-227.
Crossref
Klaus Mayerhofer, Andreas Obermair, Gudrun Windbichler, Edgar Petru, Alexandra Kaider, Lukas Hefler, Klaus Czerwenka, Sepp Leodolter & Christian Kainz. (1999) Leiomyosarcoma of the Uterus: A Clinicopathologic Multicenter Study of 71 Cases. Gynecologic Oncology 74:2, pages 196-201.
Crossref
Randi R. Nordal, Gunnar B. Kristensen, Anne Elisabeth Stenwig, Claes G. Tropé & Jahn M. Nesland. (1998) Immunohistochemical Analysis of p53 Protein in Uterine Sarcomas. Gynecologic Oncology 70:1, pages 45-48.
Crossref
René Blom, Claudio Guerrieri, Olle Stål, Henric Malmström & Ernst Simonsen. (1998) Leiomyosarcoma of the Uterus: A Clinicopathologic, DNA Flow Cytometric, p53, and mdm-2 Analysis of 49 Cases. Gynecologic Oncology 68:1, pages 54-61.
Crossref
Randi R. Nordal, Gunnar B. Kristensen, Anne Elisabeth Stenwig, Jahn M. Nesland, Erik O. Pettersen & Claes G. Trope. (1997) An Evaluation of Prognostic Factors in Uterine Carcinosarcoma. Gynecologic Oncology 67:3, pages 316-321.
Crossref
. (1996) Menopause LiteratureWatch. Journal of Women's Health 5:1, pages 85-86.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.